Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Shanrong Biotechnology (SRBT) vs. Competitors

5 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
SRBTShanrong Biotechnology$0.05$102.55K-0.00-66.42%―Unlock the SRBT analyst price target with TipRanks PremiumSRBTUnlock the SRBT top-analyst price target with TipRanks Premium
AFJKAimei Health Technology Co., Ltd$12.39$39.23M181.672.57%―Unlock the AFJK analyst price target with TipRanks PremiumSRBT vs AFJKUnlock the AFJK top-analyst price target with TipRanks Premium
UCFICN Healthy Food Tech Group$5.51$287.81M66.550.00%―Unlock the UCFI analyst price target with TipRanks PremiumSRBT vs UCFIUnlock the UCFI top-analyst price target with TipRanks Premium
OACCOaktree Acquisition Corp. III Life Sciences Class A$10.72$263.40M58.421.56%―Unlock the OACC analyst price target with TipRanks PremiumSRBT vs OACCUnlock the OACC top-analyst price target with TipRanks Premium
DMAADrugs Made In America Acquisition Corp.$10.91$264.74M55.555.67%―Unlock the DMAA analyst price target with TipRanks PremiumSRBT vs DMAAUnlock the DMAA top-analyst price target with TipRanks Premium
DMIIDrugs Made In America Acquisition II Corp.$10.24$652.29M33.803.64%―Unlock the DMII analyst price target with TipRanks PremiumSRBT vs DMIIUnlock the DMII top-analyst price target with TipRanks Premium

Performance Comparison

-200%0%200%400%600%800%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
SRBTShanrong Biotechnology0.04-0.10-68.75%
AFJKAimei Health Technology Co., Ltd12.391.3812.53%
UCFICN Healthy Food Tech Group5.510.000.00%
OACCOaktree Acquisition Corp. III Life Sciences Class A10.710.131.28%
DMAADrugs Made In America Acquisition Corp.10.900.585.67%
DMIIDrugs Made In America Acquisition II Corp.10.240.363.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts